Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Can-Fite Biopharma Ltd Sponsored ADR (Israel) (NY:CANF)

0.4226 -0.0069 (-1.61%)
Official Closing Price Updated: 8:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 151,902
Open 0.4230
Bid (Size) 0.4208 (1)
Ask (Size) 0.4400 (9)
Prev. Close 0.4295
Today's Range 0.4151 - 0.4350
52wk Range 0.4151 - 2.500
Shares Outstanding 515,746,293
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stay updated with the stocks that are on the move in today's pre-market session.
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga

Performance

YTD
-76.4%
-76.4%
1 Month
-31.1%
-31.1%
3 Month
-35.6%
-35.6%
6 Month
-62.4%
-62.4%
1 Year
-80.3%
-80.3%

More News

Read More
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Top movers in Monday's session
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
bioAffinity Technologies and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESS Newswire
Unusual volume stocks in Thursday's session
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
60 Degrees Pharmaceuticals and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESSWIRE
OS Therapies and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESSWIRE
Positive Results from Osteoarthritis Clinical Study in Dogs Reported by Can-Fite’s Partner Vetbiolix
From Can-Fite BioPharma Ltd.
Via Business Wire
Can-Fite: Breakthrough Findings Demonstrate Namodenoson Anti-cancer and Protective Effect Mechanism in the Liver
From Can-Fite BioPharma Ltd.
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Can-Fite Received IRB Approval for the Treatment of Pancreatic Cancer with Namodenoson in a Phase IIa Study
From Can-Fite BioPharma Ltd.
Via Business Wire
Can-Fite Updates on its Advanced Liver Cancer Pivotal Phase 3 Study
From Can-Fite BioPharma Ltd.
Via Business Wire
Independent Scientists Published a Review Article Demonstrating That Can-Fite Drugs Have Therapeutic Effects on Heart Diseases
From Can-Fite BioPharma Ltd.
Via Business Wire
Can-Fite to Participate in Partnering Meetings at Bio International Convention 2024
From Can-Fite BioPharma Ltd.
Via Business Wire
Join Can-Fite’s Exclusive Live Investor Webinar and Q&A Session on June 6
From Can-Fite BioPharma Ltd.
Via Business Wire
Can-Fite: 75 Oncologists and Coordinators from Europe US and Israel Participated in a Conference Aimed at Accelerating Patient Enrolment for the Pivotal Phase 3 Advanced Liver Cancer Study
From Can-Fite BioPharma Ltd.
Via Business Wire
Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESSWIRE
Can-Fite: FDA Grants IND Clearance for Namodenoson to Treat MASH Patients in a Phase IIb Study
From Can-Fite BioPharma Ltd.
Via Business Wire
Can-Fite Received Notice of Allowance from the European Patent Office for the Treatment of Erectile Dysfunction with CF602
From Can-Fite BioPharma Ltd.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Long-term Complete Response to Can-Fite's Namodenoson in Patient with Advanced Liver Cancer: Article Published in a Leading Scientific Journal
From Can-Fite BioPharma Ltd.
Via Business Wire

Frequently Asked Questions

Is Can-Fite Biopharma Ltd Sponsored ADR (Israel) publicly traded?
Yes, Can-Fite Biopharma Ltd Sponsored ADR (Israel) is publicly traded.
What exchange does Can-Fite Biopharma Ltd Sponsored ADR (Israel) trade on?
Can-Fite Biopharma Ltd Sponsored ADR (Israel) trades on the New York Stock Exchange
What is the ticker symbol for Can-Fite Biopharma Ltd Sponsored ADR (Israel)?
The ticker symbol for Can-Fite Biopharma Ltd Sponsored ADR (Israel) is CANF on the New York Stock Exchange
What is the current price of Can-Fite Biopharma Ltd Sponsored ADR (Israel)?
The current price of Can-Fite Biopharma Ltd Sponsored ADR (Israel) is 0.4226
When was Can-Fite Biopharma Ltd Sponsored ADR (Israel) last traded?
The last trade of Can-Fite Biopharma Ltd Sponsored ADR (Israel) was at 10/31/25 08:00 PM ET
What is the market capitalization of Can-Fite Biopharma Ltd Sponsored ADR (Israel)?
The market capitalization of Can-Fite Biopharma Ltd Sponsored ADR (Israel) is 217.95M
How many shares of Can-Fite Biopharma Ltd Sponsored ADR (Israel) are outstanding?
Can-Fite Biopharma Ltd Sponsored ADR (Israel) has 218M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.